This study is to evaluate the safety and efficacy of Alrex (LE ophthalmic suspension, 0.2%) versus Patanol (olopatadine hydrochloride ophthalmic solution, 0.1%) in the temporary relief of the signs and symptoms of Seasonal Allergic Conjunctivitis (SAC).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
300
1 drop of Alrex 4 times daily (QID) in both eyes at approximately 4 hour intervals for 2 weeks.
1 drop of Patanol 2 times daily (BID)at intervals of 6-8 hours or more for 2 weeks.
Bausch & Lomb Singapore
Singapore, Singapore, Singapore
Bulbar Conjunctival Injection
Bulbar conjunctival injection (sign) evaluated using a grading scale from 0-3: where 0 = Absent and 3 = Severe
Time frame: Change from baseline to day 15 (visit 3)
Ocular Itching
Ocular itching (symptom) evaluated using a grading scale from 0-4 where 0 = Absent and 4 = Severe
Time frame: Change from baseline to day 15 (visit 3)
Bulbar Conjunctival Injection
Bulbar conjunctival injection (sign) evaluated using a grading scale from 0-3: where 0 = Absent and 3 = Severe
Time frame: Change from baseline to day 8 (visit 2)
Ocular Itching
Ocular itching (symptom) evaluated using a grading scale from 0-4 where 0 = Absent and 4 = Severe
Time frame: Change from baseline to day 8 (visit 2)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.